Mouse Anti-MAP2K4 Recombinant Antibody (CBXS-5195) (CBMAB-S2412-CQ)

Name: Mouse Anti-MAP2K4 Recombinant Antibody (CBXS-5195)
SKU: CBMAB-S2412-CQ
Rating: 5 (1 reviews)

See all MAP2K4 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBXS-5195

Application

FC, IHC, WB

Immunogen

Purified recombinant fragment of human MAP2K4

Specificity

Human

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

Ascites fluid

Preservative

0.03% sodium azide

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

mitogen-activated protein kinase kinase 4

Introduction

This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. They form a three-tiered signaling module composed of MAPKKKs, MAPKKs, and MAPKs. This protein is phosphorylated at serine and threonine residues by MAPKKKs and subsequently phosphorylates downstream MAPK targets at threonine and tyrosine residues. A similar protein in mouse has been reported to play a role in liver organogenesis. A pseudogene of this gene is located on the long arm of chromosome X. Alternative splicing results in multiple transcript variants.

Entrez Gene ID

6416

UniProt ID

P45985

Alternative Names

Mitogen-Activated Protein Kinase Kinase 4; Stress-Activated Protein Kinase Kinase 1; C-Jun N-Terminal Kinase Kinase 1; JNK-Activating Kinase 1; MAP Kinase Kinase 4; MAPK/ERK Kinase 4; SAPK/ERK Kinase 1; EC 2.7.12.2; MAPKK 4; SAPKK-1; PRKMK4; SAPKK1; MEK 4;

Function

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.

Biological Process

Apoptotic processIEA:UniProtKB-KW
Cellular response to mechanical stimulusManual Assertion Based On ExperimentIEP:UniProtKB
Cellular senescenceTAS:Reactome
Fc-epsilon receptor signaling pathwayTAS:Reactome
JNK cascadeTAS:Reactome
MAPK cascadeManual Assertion Based On ExperimentIBA:GO_Central
Negative regulation of motor neuron apoptotic processIEA:Ensembl
Positive regulation of smooth muscle cell apoptotic processIEA:Ensembl
Response to woundingIEA:Ensembl
Signal transductionManual Assertion Based On ExperimentTAS:ProtInc

Cellular Location

Cytoplasm
Nucleus

PTM

Activated by phosphorylation on Ser-257 and Thr-261 by MAP kinase kinase kinases (MAP3Ks).

McNamara, B., Harold, J., Manavella, D., Bellone, S., Mutlu, L., Hartwich, T. M. P., ... & Santin, A. D. (2023). Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor. Gynecologic Oncology, 172, 65-71.

Wang, B., Yang, S., Jia, Y., Yang, J., Du, K., Luo, Y., ... & Zhu, B. (2022). PCAT19 regulates the proliferation and apoptosis of lung cancer cells by inhibiting miR-25-3p via targeting the MAP2K4 signal axis. Disease Markers, 2022.

Liu, X. D., Zhang, Z. W., Wu, H. W., & Liang, Z. Y. (2021). A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients. Pathology-Research and Practice, 217, 153313.

Matsumoto, T., Yamano, A., Murakawa, Y., Fukada, H., Sawa, M., & Kinoshita, T. (2020). Ensemble structural analyses depict the regulatory mechanism of non-phosphorylated human MAP2K4. Biochemical and Biophysical Research Communications, 521(1), 106-112.

Chou, A. H., Liao, C. C., Lee, H. C., Liou, J. T., & Liu, F. C. (2019). The MAP2K4/JNK/c-Jun Signaling Pathway Plays A Key Role In Dexmedetomidine Protection Against Acetaminophen-Induced Liver Toxicity. Drug Design, Development and Therapy, 3887-3898.

Niu, J., Li, Z., & Li, F. (2019). Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4. American Journal of Physiology-Gastrointestinal and Liver Physiology, 317(5), G670-G681.

Liu, S., Huang, J., Zhang, Y., Liu, Y., Zuo, S., & Li, R. (2019). MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis. Aging (Albany NY), 11(22), 10697.

Lu, J., Zhou, N., Yang, P., Deng, L., & Liu, G. (2019). MicroRNA-27a-3p downregulation inhibits inflammatory response and hippocampal neuronal cell apoptosis by upregulating mitogen-activated protein kinase 4 (MAP2K4) expression in epilepsy: in vivo and in vitro studies. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 25, 8499.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-MAP2K4 Recombinant Antibody (CBXS-5195)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-MAP2K4 Recombinant Antibody (CBT2366) (CAT#: V2LY-0625-LY2135)

Mouse Anti-MAP2K4 Recombinant Antibody (CBFYM-1482) (CAT#: CBMAB-M1642-FY)

Mouse Anti-MAP2K4 Recombinant Antibody (CBT877) (CAT#: V2LY-0625-LY3207)

Mouse Anti-MAP2K4 Recombinant Antibody (CBFYM-1481) (CAT#: CBMAB-M1641-FY)

Mouse Anti-MAP2K4 Recombinant Antibody (CBFYM-1484) (CAT#: CBMAB-M1644-FY)

Rabbit Anti-MAP2K4 Recombinant Antibody (CBFYM-0294) (CAT#: CBMAB-M0359-FY)

Mouse Anti-MAP2K4 Recombinant Antibody (2D10D8,4G11B2,2D10C4,2D10C3) (CAT#: CBMAB-AO715LY)

Mouse Anti-MAP2K4 Recombinant Antibody (G282-114) (CAT#: CBMAB-0358-WJ)

Rabbit Anti-MAP2K4 Recombinant Antibody (5C10) (CAT#: CBMAB-CP2388-LY)

Rabbit Anti-MAP2K4 (C-terminus) Recombinant Antibody (CBFYM-1489) (CAT#: CBMAB-M1649-FY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry